Juniper Biologics – We are a science-led healthcare company focused on Researching, Developing & Commercialising novel therapies

PIONEERING HEALTHCARE FOR THE HUMAN RACE

Innovative medicine made
accessible to those in need

Latest News

April 22, 2021

Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive

Singh to lead Juniper Biologics operations from Singapore and deliver medicines in Oncology, Rare/Orphan Diseases and Gene Therapy

Oncology

We are proud to be making a profound difference in the lives of people with cancer, by proving oncology treatments on the WHO Essential Medicines List.

Rare/Orphan Diseases

Our purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with rare diseases — often with limited or no options — so they can live their lives more fully.

Gene Therapy

Our innovative treatments are based on first in class cell and gene therapy designed to treat osteoarthritis through the regeneration of cartilage. This offers substantial relief for osteoarthritis patients who would otherwise be in need of surgery.